Focus Partners Wealth’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.5M Sell
52,105
-7,754
-13% -$362K ﹤0.01% 1218
2025
Q4
$2.9M Sell
59,859
-13,849
-19% -$686K ﹤0.01% 1173
2025
Q3
$3.48M Buy
73,708
+4,442
+6% +$214K 0.01% 859
2025
Q2
$3.35M Sell
69,266
-3,388
-5% -$173K 0.01% 786
2025
Q1
$4.03M Buy
72,654
+446
+0.6% +$24.1K 0.01% 688
2024
Q4
$3.48M Buy
72,208
+6,195
+9% +$315K 0.01% 710
2024
Q3
$3.8M Buy
66,013
+15,853
+32% +$856K 0.01% 626
2024
Q2
$2.43M Buy
50,160
+2,803
+6% +$135K 0.01% 622
2024
Q1
$2.3M Buy
47,357
+12,230
+35% +$597K 0.02% 454
2023
Q4
$1.75M Buy
+35,127
New +$1.72M 0.02% 370

Other funds holding SNY

Focus Partners Wealth's SNY Position: Q1 2026 in Review

Focus Partners Wealth reduced its Sanofi (SNY) stake by 13% in Q1 2026, selling an estimated $362K and leaving 52,105 shares worth $2.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1218.

Focus Partners Wealth first reported a position in SNY in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.03M in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Focus Partners Wealth held 52,105 shares of Sanofi worth $2.5M as of Q1 2026.
  • Focus Partners Wealth sold 7,754 Sanofi shares in Q1 2026, an estimated $362K.
  • Sanofi made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #1218 holding.
  • Focus Partners Wealth first reported a position in Sanofi in Q4 2023 and has held it in 10 quarters since.
  • Focus Partners Wealth's Sanofi position peaked at $4.03M in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.